Oncology Meeting Resources
- 14 Mar 2015,
The 2015 Symposium concentrated on targeting the MAPK pathway: from RAS to MEK. The programme covered preclinical data and genetics relevant for the understanding of the functional mechanisms in the RAS/ERK/MEK pathway, regulation of MAPK signalling, the rationale and strategies to inhibiting the pathway, biomarkers, mechanisms of resistance, as well as how to overcome it, and some important interactions with other pathways.
On this page, ESMO members may view the slide sets and webcasts of presentations given at the ESMO Symposium on Signalling Pathways in Cancer 2015 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.